Obermatt

Translational Development Acquisition

NMQ:TDAC · KYG9008W1050
Capital MarketsSmall

360° View

no current rank
Price/Sales
Price/Earnings69
Price/Book61
Dividend Yield
Revenue Growth
Profit Growth83
Capital Growth53
TSR 52w98
Leverage8
Liquidity
Refinancing69
Combined
Analyst Opinions
Pro Holdings77
Opinion Changes
Market Pulse1

Profile

CountryUSA
IndustryCapital Markets
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2022
ISINKYG9008W1050
Last UpdateApr 2, 2026

Description

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or mor…

Similar Stocks

The companies this stock is ranked against.

Compare Translational Development Acquisition with its peers
Vendome Acquisition Corp I
NMQ:VNME
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Siddhi Acquisition
NMQ:SDHI
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Republic Digital Acquisition
NMQ:RDAG
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Quantumsphere Acquisition
NMQ:QUMS
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
NMP Acquisition
NMQ:NMP
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
McKinley Acquisition
NMQ:MKLY
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →